Black women are more likely than white women to schedule a uterine-sparing treatment for leiomyomas

Ganesa Wegienka, Elizabeth A. Stewart, Wanda K. Nicholson, Shuaiqi Zhang, Fan Li, Laine Thomas, James B. Spies, Sateria Venable, Shannon Laughlin-Tommaso, Michael P. Diamond, Raymond M. Anchan, George Larry Maxwell, Erica E. Marsh, Evan R. Myers, Anissa I. Vines, Lauren A. Wise, Kedra Wallace, Vanessa L. Jacoby

Research output: Contribution to journalArticlepeer-review

Abstract

Background: To evaluate differences in the proportion of uterine fibroid (UF) treatments that are uterine-sparing between Black women and White women and identify factors that could explain disparities. Methods: Women at age 18-54 years who were enrolled from 10 clinical sites in the United States into the Comparing Options for Management: Patient-Centered Results for UFs (COMPARE-UF) treatment registry completed questionnaires before their UF procedure. UF symptoms and quality of life were assessed by questionnaires. Details on UF imaging and treatment (hysterectomy, myomectomy, or uterine artery embolization [UAE]) were collected from each patient's medical record. Random-effects logistic regression was used to assess the association between race and the odds of having a uterine-sparing procedure versus hysterectomy. Subgroup analyses compared each uterine-sparing procedure with hysterectomy. Results: In this cohort of 1141 White women and 1196 Black women, Black women tended to be younger (median 41.0 vs. 42.0 years) and report worse symptoms, pain, and function on every scale compared with White women. Black women were more likely to have had a prior UF treatment compared with White women (22.8% vs. 14.6%). White women had more hysterectomies (43.6% vs. 32.2%) and myomectomies (50.9% vs. 50.2%) versus Black women. Black women had more UAEs (15.1% vs. 4.7%) than White women. After adjusting for clinical site and other variables, Black women had greater odds than White women of having a myomectomy (odds ratio [OR] = 2.41, 95% confidence interval [CI] = 1.63-3.56) or a UAE versus hysterectomy (OR = 4.24, 95% CI = 2.41-7.46). Conclusion: In these participants, Black women were more likely to schedule a uterine-sparing UF treatment and a nonsurgical UF treatment than their White counterparts; this may not be true for all women. Longer comparative effectiveness studies are needed to inform women about the durability of UF treatments. Greater understanding of factors influencing treatment selection is needed as are studies that include women without access to tertiary care centers. Clinical Trial Registration: Clinicaltrials.gov, NCT02260752 (enrollment start: November 2015).

Original languageEnglish (US)
Pages (from-to)355-366
Number of pages12
JournalJournal of Women's Health
Volume30
Issue number3
DOIs
StatePublished - Mar 2021

Keywords

  • hysterectomy
  • myomectomy
  • racial differences
  • uterine artery embolization
  • uterine fibroids

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Black women are more likely than white women to schedule a uterine-sparing treatment for leiomyomas'. Together they form a unique fingerprint.

Cite this